83 related articles for article (PubMed ID: 10631689)
1. The randomized trials of dose-intensive therapy for breast cancer: what do they mean for patient care and where do we go from here?
Weiss RB
Oncologist; 1999; 4(6):450-8. PubMed ID: 10631689
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
3. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
4. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
5. The current look at high-dose chemotherapy in breast cancer minireview.
Filip S; Petera J; Odrázka K; Bláha M
Neoplasma; 2000; 47(5):261-8. PubMed ID: 11130240
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy for breast cancer.
Hudis CA; Münster PN
Semin Oncol; 1999 Feb; 26(1):35-47. PubMed ID: 10073560
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
8. Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).
Antman K
Trans Am Clin Climatol Assoc; 2002; 113():56-66; discussion 66-7. PubMed ID: 12053718
[TBL] [Abstract][Full Text] [Related]
9. The verdict is not in yet. Analysis of the randomized trials of high-dose chemotherapy for breast cancer.
Nieto Y
Haematologica; 2003 Feb; 88(2):201-11. PubMed ID: 12604410
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy in breast cancer -- the perils of history uncontrolled.
Miller KD; Sledge GW
Medscape Womens Health; 2000; 5(3):E1. PubMed ID: 11109042
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
12. [High-dose chemotherapy for metastatic breast cancer].
Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
[TBL] [Abstract][Full Text] [Related]
13. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy of breast cancer.
Kaklamani VG; Gradishar WJ
Cancer Invest; 2005; 23(6):548-60. PubMed ID: 16203663
[TBL] [Abstract][Full Text] [Related]
17. [Dose density and dose intensity in the treatment of breast cancer].
Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
[TBL] [Abstract][Full Text] [Related]
18. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
Monnier A
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1355-9. PubMed ID: 17069521
[TBL] [Abstract][Full Text] [Related]
19. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
20. Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.
Ingle JN
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):900s-5s. PubMed ID: 15701884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]